Managing Safety Reporting in the Evolving Regulatory Environment of the Asia-Pacific Region
About this webinar
Managing safety cases is becoming more complex due to the ever-increasing volume and variety of data. In the Asia Pacific region specifically regulatory and legal requirements vary from country to country and this is additionally layered by intricate country language requirements.
Over the last few years, pharmacovigilance requirements have evolved considerably and more changes are on the horizon.
This webinar will provide an insight into safety regulations in Taiwan, China, and Japan, delving deeper into the recent and upcoming safety regulations in Korea, to support understanding and compliance in pharmacovigilance. It will cover the latest regulatory intelligence, medical writing customisations and explore methods to achieve operational efficiency through system optimization.
Who should attend
- Outsourcing
- Procurement
- Quality Assurance
- Project Management
- Pharmacovigilance
- Safety Reporting
- Medical Affairs
- Regulatory Affairs
- Medical Writing
- Clinical Trials
- Post-Marketing
What you will learn
- Regulatory requirements in APAC region relating to: E2B R3 regulatory requirements
- Periodic reporting
- Implementation approach for evolving requirements
- DSUR/PSUR process and customisation requirements
- Understanding of technology system to achieve safety reporting efficiency
Featured Speakers
Si-Nae Lee
Si-Nae has almost 17 years of pharmaceutical industry experience and has worked in v
Mary Pilkington, PhD
Mary is a Medical Writing Manager based in the UK who has worked in the CRO industry for over 15 years. She has experience writing numerous document types over a range of therapeutic areas and specialises in aggregate safety reports (clinical and post-marketing phases), leading the aggregate report writing group. She is the author and owner of many of the ICON SOPs and WPs (including the DSUR and PSUR WPs), develops aggregate report templates and is the primary trainer of ICON’s Medical Writers in aggregate report writing. Mary holds a first class honors BSc in Zoology from Swansea University and a PhD in Physiology from the University of Western Ontario.
Partner for this event
ICON
ICON plc is a global provider of outsourced drug and device development and commercialization services to pharmaceutical, biotechnology, medical device, and government and public health organisations. The company specialises in the strategic development, management and analysis of programs that support clinical development from compound selection to Phase I-IV clinical studies. With headquarters in Dublin, Ireland, ICON currently operates from 98 locations in 40 countries and has approximately 15,200 employees.